Organization Overview
Alternative names
naxitamab (Danyelza) (2020 NDA)
Desmoplastic Small Round Cell Tumor (Phase 2)
Medulloblastoma (Phase 2)
Meningeal Carcinomatosis (Phase 3)
Neoplasm Metastasis (Phase 3)
Neoplasms, Second Primary (Phase 3)
Neuroblastoma (Phase 3)